In-hospital outcomes of transcatheter aortic valve implantation procedure: data of single-center registry

Transcatheter aortic valve replacement is an appropriate alternative to open surgery in some patients with severe aortic stenosis who have significant comorbidities and high surgical risk.

Aim. To evaluate the immediate results of transcatheter aortic valve replacement in patients with severe aortic stenosis.

Material and Methods. This is a retrospective study, which included 350 patients who underwent transcatheter aortic valve replacement from 2015 to 2021. Mortality, complications, clinical data, and echocardiographic parameters were assessed in the early postoperative period after the procedure.

Results. The patient mean age was 75.3 ± 7.2 years. The majority of patients had intermediate surgical risk: EuroScore II of 6.7 ± 5.4 and STS-PROM score of 3.3 ± 1.9. In most cases, there was severe hypertrophy of left ventricular (LV) myocardium with an average LV myocardial mass of 330.9 ± 88.4 g. The average postprocedural pressure gradient across the aortic valve was 8.9 ± 4.4 mm Hg. The most common procedural complication was complete heart block (10%). In-hospital mortality rate was 1.7%.

Conclusion. Our register demonstrated the optimal immediate clinical and echocardiographic results of transcatheter aortic valve replacement in patients with severe aortic stenosis.

1. A guide to cardiovascular surgery; by ed. V.I. Burakovsky, L.A. Bockeria; 2nd ed. Moscow: Medicine; 1996:768. (In Russ.).

2. Akodad M., Schurtz G., Adda J., Leclercq F., Roubille F. Management of valvulopathies with acute severe heart failure and cardiogenic shock. Arch. Cardiovasc. Dis. 2019;112(12):773–780. DOI: 10.1016/j.acvd.2019.06.009.

3. Vahanian A., Beyersdorf F., Praz F., Milojevic M., Baldus S., Bauersachs J. et al. 2021 ESC/EACTS Guidelines for the management of valvular heart disease. Eur. Heart J. 2021;ehab395. DOI: 10.1093/eurheartj/ehab395.

4. Díez-Villanueva P., Salamanca J., Rojas A., Alfonso F. Importance of frailty and comorbidity in elderly patients with severe aortic stenosis. J. Geriatr. Cardiol. 2017;14(6):379–382. DOI: 10.11909/j.issn.1671-5411.2017.06.005.

5. Zubarev D.D., Kretov E.I., Khelimskiy D.A., Naidenov R.A., Biryucov A.V., Prokhorikhin A.A. et al. Results of one-stage intervention in patients with concomitant coronary artery disease and aortic valve stenosis. Circulation Pathology and Cardiac Surgery. 2016;20(3):31–41 (In Russ.). DOI: 10.21688-1681-3472-2016-3-31-41.

6. Nashef S.A.M., Roques F., Sharples L.D., Nilsson J., Smith C., Goldstone A.R. et al. EuroSCORE II. Eur. J. Cardiothorac Surg. 2012;41(4):734–744. DOI: 10.1093/ejcts/ezs043.

7. Shahian D.M., O’Brien S.M., Filardo G., Ferraris V.A., Haan C.K., Rich J.B. et al. The Society of Thoracic Surgeons 2008 cardiac surgery risk models: Part 1 – coronary artery bypass grafting surgery. Ann. Thorac. Surg. 2009;88(1):S2–22. DOI: 10.1016/j.athoracsur.2009.05.053.

8. Rogers T., Thourani V.H., Waksman R. Transcatheter aortic valve replacement in intermediate- and low-risk patients. J. Am. Heart Assoc. 2018;7(10):e007147. DOI: 10.1161/JAHA.117.007147.

9. Siordia J.A. Jr., Loera J.M., Scanlon M., Evans J., Knight P.A. Three-year survival comparison between transcatheter and surgical aortic valve replacement in intermediate- and low-risk patients. Innovations (Phila). 2018;13(3):153–162. DOI: 10.1097/IMI.0000000000000507.

10. Leon M.B., Smith C.R., Mack M.J., Makkar R.R., Svensson L.G., Kodali S.K. et al. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N. Engl. J. Med. 2016;374(17):1609–1620. DOI: 10.1056/NEJMoa1514616.

11. Reardon M.J., Van Mieghem N.M., Popma J.J., Kleiman N.S., Sondergaard L., Mumtaz M. et al. Surgical or transcatheter aortic-valve replacement in intermediate-risk patients. N. Engl. J. Med. 2017;376(14):1321–1331. DOI: 10.1056/NEJMoa1700456.

12. Braghiroli J., Kapoor K., Thielhelm T.P., Ferreira T., Cohen M.G. Transcatheter aortic valve replacement in low risk patients: A review of PARTNER 3 and Evolut low risk trials. Cardiovasc. Diagn. Ther. 2020;10(1):59–71. DOI: 10.21037/cdt.2019.09.12.

13. Popma J.J., Deeb G.M., Yakubov S.J., Mumtaz M., Gada H., O’Hair D. et al. Trans-catheter aortic-valve replacement with a self-expanding valve in low-risk patients. N. Engl. J. Med. 2019;380(18):1706–1715. DOI: 10.1056/NEJMoa1816885.

14. Serruys P.W., Modolo R., Reardon M., Miyazaki Y., Windecker S., Popma J. et al. One-year outcomes of patients with severe aortic stenosis and an STS PROM of less than three percent in the SURTAVI trial. EuroIntervention. 2018;14(8):877–883. DOI: 10.4244/EIJ-D-18-00460.